Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-6-28
pubmed:abstractText
To assess the virologic and immunologic response to a boosted double-protease inhibitor (PI) regimen of highly pretreated patients infected with HIV-1 and to examine the role of PI resistance and concentration of serum saquinavir.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1528-4336
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-72
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15983890-Adult, pubmed-meshheading:15983890-Antiretroviral Therapy, Highly Active, pubmed-meshheading:15983890-Benzoxazines, pubmed-meshheading:15983890-CD4 Lymphocyte Count, pubmed-meshheading:15983890-Female, pubmed-meshheading:15983890-HIV Infections, pubmed-meshheading:15983890-HIV Protease Inhibitors, pubmed-meshheading:15983890-HIV-1, pubmed-meshheading:15983890-Humans, pubmed-meshheading:15983890-Lamivudine, pubmed-meshheading:15983890-Lopinavir, pubmed-meshheading:15983890-Male, pubmed-meshheading:15983890-Middle Aged, pubmed-meshheading:15983890-Oxazines, pubmed-meshheading:15983890-Pyrimidinones, pubmed-meshheading:15983890-Reverse Transcriptase Inhibitors, pubmed-meshheading:15983890-Ritonavir, pubmed-meshheading:15983890-Salvage Therapy, pubmed-meshheading:15983890-Saquinavir, pubmed-meshheading:15983890-Viral Load
pubmed:articleTitle
Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients.
pubmed:affiliation
Immunodeficiency Service, Montreal Chest Institute, McGill University Health Centre, 3650 rue St-Urbain, Montreal, Quebec, H2X 2P4 Canada.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't